These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3933246)

  • 1. Anaemia and agranulocytosis associated with ticlopidine therapy.
    Guerciolini R; Giordano G; Aversa F; Del Favero A
    Acta Haematol; 1985; 73(4):232-4. PubMed ID: 3933246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bone marrow culture in patients treated with Ticlopidine].
    Resegotti L; Pistone MA; Testa D; Charbonnier R; Toselli P; Vivalda S
    Nouv Rev Fr Hematol (1978); 1985; 27(1):19-22. PubMed ID: 4039435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Agranulocytosis caused by ticlopidine].
    Marmont AM; Lotti G; Nati S; Martinengo M; Morgano A
    Recenti Prog Med; 1985 May; 76(5):245-8. PubMed ID: 4023387
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hematological toxicity of ticlopidine? (author's transl)].
    de Gramont A; Canuel C; Krulik M; Bauters F; Degos L; Marty M; Najean Y
    Nouv Rev Fr Hematol (1978); 1982; 24(1):35-7. PubMed ID: 7071010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cholestatic icterus and agranulocytosis due to ticlopidine].
    Saint-Marc Girardin MF; Cordonnier C
    Gastroenterol Clin Biol; 1982; 6(8-9):716-7. PubMed ID: 7129024
    [No Abstract]   [Full Text] [Related]  

  • 6. [Side effects of ticlopidine; clinical observation and immunological study].
    de Fraiture WH; Claas FH; Meyboom RH
    Ned Tijdschr Geneeskd; 1982 Jun; 126(23):1051-4. PubMed ID: 6213869
    [No Abstract]   [Full Text] [Related]  

  • 7. Agranulocytosis caused by ticlopidine and its mechanism.
    Ono K; Kurohara K; Yoshihara M; Shimamoto Y; Yamaguchi M
    Am J Hematol; 1991 Aug; 37(4):239-42. PubMed ID: 1858780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible severe anaemia and granulocytopenia caused by procainamide. A case report.
    van Beek RJ; Bieger R; den Ottolander GJ
    Scand J Haematol; 1978 Aug; 21(2):150-2. PubMed ID: 694426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ticlopidine-induced severe agranulocytosis after the placement of coronary artery stent--a case report.
    Sari R; Sevinc A; Buyukberber S
    Angiology; 2000 Jul; 51(7):591-3. PubMed ID: 10917583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible mechanism of action of ticlopidine on committed granulocyte macrophage precursors.
    Quaglino D; Salladini G; Ricciotti M
    Haematologica; 1984; 69(3):257-62. PubMed ID: 6432638
    [No Abstract]   [Full Text] [Related]  

  • 11. Agranulocytosis associated with ticlopidine: a possible benefit with filgastim.
    Marinella MA
    Ann Clin Lab Sci; 1997; 27(6):418-21. PubMed ID: 9433539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ticlopidine-induced aplastic anemia: two new case reports, review, and meta-analysis of 55 additional cases.
    Symeonidis A; Kouraklis-Symeonidis A; Seimeni U; Galani A; Giannakoulas N; Fragopanagou E; Tiniakou M; Matsouka P; Zoumbos N
    Am J Hematol; 2002 Sep; 71(1):24-32. PubMed ID: 12221670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mainly neutropenic pancytopenia caused by acute bone marrow depression during ticlopidine treatment].
    Montanari G; Mussida M; Scarabelli C; Zinzalini G
    Clin Ter; 1987 Oct; 123(2):111-4. PubMed ID: 2972472
    [No Abstract]   [Full Text] [Related]  

  • 14. Necrotizing gingivitis: a possible oral manifestation of ticlopidine-induced agranulocytosis.
    Rajandram RK; Ramli R; Karim F; Rahman RA; Fun LC
    N Z Med J; 2007 Jun; 120(1256):U2590. PubMed ID: 17589558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of ticlopidine by activated neutrophils: implications for ticlopidine-induced agranulocytosis.
    Liu ZC; Uetrecht JP
    Drug Metab Dispos; 2000 Jul; 28(7):726-30. PubMed ID: 10859143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abacavir-induced febrile agranulocytosis and anaemia.
    Calza L; Dentale N; Piergentili B; Rosseti N; Cascavilla A; Trapani FF; Pocaterra D; Manfredi R
    AIDS; 2008 Oct; 22(16):2221-2. PubMed ID: 18832890
    [No Abstract]   [Full Text] [Related]  

  • 17. Life-threatening agranulocytosis, anemia, and plasmacytosis after dipyrone use for fever in a child.
    Işık M; Kaya Z; Belen FB; Aktaş AT; Tezer H; Gürsel T
    J Pediatr Hematol Oncol; 2014 Jan; 36(1):e46-8. PubMed ID: 23007418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocainide-induced reversible agranulocytosis and anemia.
    Soff GA; Kadin ME
    Arch Intern Med; 1987 Mar; 147(3):598-9. PubMed ID: 3103562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Agranulocytosis probably induced by thenalidine (Sandosten comp.)].
    Holmgren EB; Jonsson M
    Lakartidningen; 1975 Jan; 72(1-2):70-1. PubMed ID: 235058
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acute drug cytopenia. Apropos of 11 cases].
    Varet B; Gluckman E; Reyes F; Basch A; Dreyfus B
    Ann Med Interne (Paris); 1971 Apr; 122(4):525-30. PubMed ID: 4104093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.